Chebib Fouad T, Jung Yeonsoon, Heyer Christina M, Irazabal Maria V, Hogan Marie C, Harris Peter C, Torres Vicente E, El-Zoghby Ziad M
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA.
Division of Nephrology, Kosin University College of Medicine, Busan, South Korea.
Nephrol Dial Transplant. 2016 Jun;31(6):952-60. doi: 10.1093/ndt/gfw008. Epub 2016 Feb 29.
The autosomal dominant polycystic kidney disease (APDKD) genotype influences renal phenotype severity but its effect on polycystic liver disease (PLD) is unknown. Here we analyzed the influence of genotype on liver phenotype severity.
Clinical data were retrieved from electronic records of patients who were mutation screened with the available liver imaging (n = 434). Liver volumes were measured by stereology (axial or coronal images) and adjusted to height (HtLV).
Among the patients included, 221 (50.9%) had truncating PKD1 (PKD1-T), 141 (32.5%) nontruncating PKD1 (PKD1-NT) and 72 (16.6%) PKD2 mutations. Compared with PKD1-NT and PKD2, patients with PKD1-T had greater height-adjusted total kidney volumes (799 versus 610 and 549 mL/m; P < 0.001). HtLV was not different (1042, 1095 and 1058 mL/m; P = 0.64) between the three groups, but females had greater HtLVs compared with males (1114 versus 1015 mL/m; P < 0.001). Annualized median liver growth rates were 1.68, 1.5 and 1.24% for PKD1-T, PKD1-NT and PKD2 mutations, respectively (P = 0.49), and remained unaffected by the ADPKD genotype when adjusted for age, gender and baseline HtLV. Females <48 years of age had higher annualized growth rates compared with those who were older (2.65 versus 0.09%; P < 0.001). After age 48 years, 58% of females with severe PLD had regression of HtLV, while HtLV continued to increase in males.
In contrast to the renal phenotype, the ADPKD genotype was not associated with the severity or growth rate of PLD in ADKPD patients. This finding, along with gender influence, indicates that modifiers beyond the disease gene significantly influence the liver phenotype.
常染色体显性多囊肾病(APDKD)的基因型会影响肾脏表型的严重程度,但其对多囊肝病(PLD)的影响尚不清楚。在此,我们分析了基因型对肝脏表型严重程度的影响。
从接受了可用肝脏成像检查的患者电子记录中检索临床数据(n = 434)。通过体视学方法(轴向或冠状图像)测量肝脏体积,并根据身高进行调整(HtLV)。
在纳入的患者中,221例(50.9%)有截短型PKD1(PKD1-T)突变,141例(32.5%)有非截短型PKD1(PKD1-NT)突变,72例(16.6%)有PKD2突变。与PKD1-NT和PKD2患者相比,PKD1-T患者的身高调整后总肾体积更大(分别为799、610和549 mL/m;P < 0.001)。三组之间的HtLV无差异(分别为1042、1095和1058 mL/m;P = 0.64),但女性的HtLV高于男性(分别为1114和1015 mL/m;P < 0.001)。PKD1-T、PKD1-NT和PKD2突变患者的肝脏年中位生长率分别为1.68%、1.5%和1.24%(P = 0.49),在根据年龄、性别和基线HtLV进行调整后,肝脏年中位生长率不受APDKD基因型的影响。48岁以下的女性年生长率高于年龄较大的女性(分别为2.65%和0.09%;P < 0.001)。48岁以后,58%患有严重PLD的女性HtLV有所下降,而男性的HtLV则持续增加。
与肾脏表型不同,APDKD患者的APDKD基因型与PLD的严重程度或生长率无关。这一发现以及性别影响表明,疾病基因以外的修饰因子对肝脏表型有显著影响。